CD4 and non-Hodgkin lymphoma: Further, a study by the AIDS Malignancy Consortium found that immunotherapy may be associated with improved outcomes in HIV-associated NHL when excluding patients with a CD4 count less than 50/mm3 who had an increased risk of death due to infectious causes [41].